Condition: Meningoccocal Disease · Sponsor: Serum Institute of India Pvt. Ltd.
This study will measure immune persistence of the NmCV-5 more than 5 years after a single dose vaccination in participants 2-29 years of age in Mali and The Gambia.
This description comes directly from the study's public registry record.
Dr Prasad Kulkarni, MD, FRCP · +91-20-71946820 · drpsk@seruminstitute.com
Always discuss trial participation with your own doctor first.
| Centre pour le Développement des Vaccins du Mali, ex-Institut Marchoux, Ministry of Health, BP251 Bamako, Mali BP251 | Bamako, Mali | Recruiting |
| Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia | Banjul, The Gambia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07379151